Locations:

Tag: cerebral embolic protection

medical device deployed in the human heart

December 9, 2024/Heart, Vascular and Thoracic/Interventional Cardiology

Assessing Efficacy of Cerebral Embolic Protection in TAVR by Geography

Post hoc analysis of PROTECTED TAVR finds reduced stroke risk in the U.S. but not beyond

sentinel cerebral protection device capturing embolic debris

August 27, 2024/Heart, Vascular and Thoracic/Heart Valve Disease

More Evidence That Embolic Protection Reduces Disabling Stroke Risk During TAVR

Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke

September 22, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

PROTECTED TAVR Finds Reduced Rate of Disabling Stroke With Cerebral Embolic Protection

Results from largest randomized trial of the technology to date

June 15, 2017/Heart, Vascular and Thoracic/News & Insights

Cerebral Protection in TAVR: Approval Marks Start of a New Era

Safety considerations prevail in FDA decision on Sentinel device

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next